Structure of the N-terminal domain of human thioredoxin-interacting protein

被引:21
|
作者
Polekhina, Galina [1 ]
Ascher, David Benjamin [2 ]
Kok, Shie Foong [1 ]
Beckham, Simone [1 ,3 ]
Wilce, Matthew [3 ]
Waltham, Mark [2 ]
机构
[1] Monash Univ, Ctr Canc Res, Monash Inst Med Res, Clayton, Vic 3168, Australia
[2] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia
[3] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia
基金
澳大利亚国家健康与医学研究理事会; 澳大利亚研究理事会; 英国医学研究理事会;
关键词
thioredoxin-interacting protein; arrestins; diabetes; metabolism; glucose uptake; UP-REGULATED PROTEIN-1; OXIDATIVE STRESS; CRYSTAL-STRUCTURE; RECEPTOR-BINDING; VISUAL ARRESTIN; GLUCOSE; VDUP1; TXNIP; EXPRESSION; CANCER;
D O I
10.1107/S0907444912047099
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Thioredoxin-interacting protein (TXNIP) is one of the six known -arrestins and has recently received considerable attention owing to its involvement in redox signalling and metabolism. Various stress stimuli such as high glucose, heat shock, UV, H2O2 and mechanical stress among others robustly induce the expression of TXNIP, resulting in the sequestration and inactivation of thioredoxin, which in turn leads to cellular oxidative stress. While TXNIP is the only -arrestin known to bind thioredoxin, TXNIP and two other -arrestins, Arrdc4 and Arrdc3, have been implicated in metabolism. Furthermore, owing to its roles in the pathologies of diabetes and cardiovascular disease, TXNIP is considered to be a promising drug target. Based on their amino-acid sequences, TXNIP and the other -arrestins are remotely related to -arrestins. Here, the crystal structure of the N-terminal domain of TXNIP is reported. It provides the first structural information on any of the -arrestins and reveals that although TXNIP adopts a -arrestin fold as predicted, it is structurally more similar to Vps26 proteins than to -arrestins, while sharing below 15% pairwise sequence identity with either.
引用
收藏
页码:333 / 344
页数:12
相关论文
共 50 条
  • [1] Crystallization and preliminary X-ray analysis of the N-terminal domain of human thioredoxin-interacting protein
    Polekhina, Galina
    Ascher, David Benjamin
    Kok, Shie Foong
    Waltham, Mark
    ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2011, 67 : 613 - 617
  • [2] Crystallographic studies of thioredoxin-interacting protein
    Polekhina, Galina
    Kok, Shie Foong
    Ascher, David Benjamin
    Waltham, Mark
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2011, 67 : C309 - C309
  • [3] Thioredoxin-Interacting Protein in Cancer and Diabetes
    Masutani, Hiroshi
    ANTIOXIDANTS & REDOX SIGNALING, 2022, 36 (13) : 1001 - 1022
  • [4] Posttranslational regulation of thioredoxin-interacting protein
    Robinson, Katherine A.
    Brock, Jonathan W.
    Buse, Maria G.
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2013, 50 (01) : 59 - 71
  • [5] Solution NMR structure of the N-terminal domain of the human DEK protein
    Devany, Matthew
    Kappes, Ferdinand
    Chen, Kuan-Ming
    Markovitz, David M.
    Matsuo, Hiroshi
    PROTEIN SCIENCE, 2008, 17 (02) : 205 - 215
  • [6] The structural basis for the negative regulation of thioredoxin by thioredoxin-interacting protein
    Jungwon Hwang
    Hyun-Woo Suh
    Young Ho Jeon
    Eunha Hwang
    Loi T. Nguyen
    Jeonghun Yeom
    Seung-Goo Lee
    Cheolju Lee
    Kyung Jin Kim
    Beom Sik Kang
    Jin-Ok Jeong
    Tae-Kwang Oh
    Inpyo Choi
    Jie-Oh Lee
    Myung Hee Kim
    Nature Communications, 5
  • [7] The structural basis for the negative regulation of thioredoxin by thioredoxin-interacting protein
    Hwang, Jungwon
    Suh, Hyun-Woo
    Jeon, Young Ho
    Hwang, Eunha
    Nguyen, Loi T.
    Yeom, Jeonghun
    Lee, Seung-Goo
    Lee, Cheolju
    Kim, Kyung Jin
    Kang, Beom Sik
    Jeong, Jin-Ok
    Oh, Tae-Kwang
    Choi, Inpyo
    Lee, Jie-Oh
    Kim, Myung Hee
    NATURE COMMUNICATIONS, 2014, 5 : 10 - 23
  • [8] Thioredoxin-interacting protein suppresses bladder carcinogenesis
    Nishizawa, Koji
    Nishiyama, Hiroyuki
    Matsui, Yoshiyuki
    Kobayashi, Takashi
    Saito, Ryoichi
    Kotani, Hirokazu
    Masutani, Hiroshi
    Oishi, Shinya
    Toda, Yoshinobu
    Fujii, Nobutaka
    Yodoi, Junji
    Ogawa, Osamu
    CARCINOGENESIS, 2011, 32 (10) : 1459 - 1466
  • [9] Thioredoxin-interacting protein and chronic lymphocytic leukemia
    Friday, E.
    Koshy, N.
    Bhanderi, V.
    Turturro, F.
    LEUKEMIA & LYMPHOMA, 2012, 53 (03) : 492 - 494
  • [10] Thioredoxin-interacting protein is killing my β-cells!
    Corbett, John A.
    DIABETES, 2008, 57 (04) : 797 - 798